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Abstract
Introduction: Recent data indicate a hierarchical organization of many solid cancers, including breast cancer, with
a small number of cancer initiating cells (CICs) that have the ability to self-renew and exhibit multi-lineage potency.
We, and others, have demonstrated that CICs in breast cancer and glioma are relatively resistant to ionizing
radiation if compared to their non-tumorigenic counterparts. However, the extent of the remaining self-renewing
capacity of CICs after fractions of radiation is currently unknown. We hypothesized that CICs, in contrast to their
non-tumorigenic counterparts, not only survive fractions of ionizing radiation but also retain the CIC phenotype as
defined by operational means.
Methods: We used two marker systems to identify breast CICs (CD24
-/low/CD44
high, or lack of proteasome activity)
and performed sphere-forming assays after multiple clinical fractions of radiation. Lineage tracking was performed
by membrane staining. Cell cycle distribution and RNA content were assessed by flow cytometry and senescence
was assessed via b-galactosidase staining.
Results: We demonstrated that irradiated CICs survived and retained their self-renewal capacity for at least four
generations. We show that fractionated radiation not only spared CICs but also mobilized them from a quiescent/
G0 phase of the cell cycle into actively cycling cells, while the surviving non-tumorigenic cells were driven into
senescence.
Conclusions: The breast CIC population retains increased self-renewal capacity over several generations and
therefore, we conclude that increases in the number of CICs after sublethal doses of radiation have potential
clinical importance. Prevention of this process may lead to improved clinical outcome.
Introduction
Recent experimental data provide evidence for a hier-
archical structure of many solid cancers [1-7] including
breast cancer [8]. Using surface markers, a small popula-
tion of highly tumorigenic breast cancer initiating cells
(CICs) has been prospectively identified, which exhibits
a cancer stem cell phenotype, thus being able to self-
renew and to give rise to progeny of multiple different
lineages of differentiated cells [8]. We previously
demonstrated that this population of cells was relatively
resistant against ionizing radiation if compared to their
non-tumorigenic counterparts [9]. Two other groups
have confirmed our data [10,11]. Additionally, Han and
Crowe recently identified a side population in MCF7
and T47D breast cancer cells [12], which initiated
tumors in vivo and was more resistant to ionizing radia-
tion than the non-side population. Furthermore, we, and
others, have reported that the population of CICs
increases during the course of fractionated radiation
[9,13]. However, the extent of the remaining self-renew-
ing capacity of this CIC population after fractions of
radiation is currently unknown. This information is cru-
cial for evaluating the significance of radiation resistance
of CICs.
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patient derived samples by Al-Hajj et al. using antibo-
dies against ESA, CD24, and CD44 [8], and later vali-
dated for established breast cancer cell lines [14]. The
labeling of CICs using antibodies or enzyme substrates
[15] has been an invaluable tool to study the features of
CICs. Nevertheless, both techniques have disadvantages,
which make it difficult to study living CICs in-situ or
in-vivo. To overcome this problem, we recently devel-
oped an imaging system for breast and glioma CICs that
allows for identification and tracking of CICs without
the need for antibodies or exogenous enzyme substrates
[16]. It is based on the observation that CICs lack 26S
proteasome function. In cell lines engineered to express
a fusion protein between the fluorescent protein
ZsGreen and the C-terminal degron of murine ornithine
decarboxylase (cODC), CICs can be identified via fluor-
escent imaging due to the accumulation of ZsGreen-
cODC protein while non-tumorigenic cells degrade this
protein immediately after translation.
In the present study, we hypothesized that CICs, in
contrast with their non-tumorigenic counterparts, not
only survive fractions of ionizing radiation but also
retain the CIC phenotype as defined by operational
means and may even become more aggressive than
populations of non-irradiated control CICs. Using two
distinct marker systems to identify breast CICs (CD24
-/
low/CD44
high, or lack of proteasome activity) and sphere
forming assays, developed by Dontu et al., to enrich for
normal mammary stem cells/progenitors [17], we
demonstrated that cycling cell populations were
enriched for CICs after irradiation with fractions of 2 or
3 Gray (Gy). Irradiated CICs not only survived but also
retained their self-renewal capacity for at least four gen-
erations. CICs were resistant to radiation-induced apop-
tosis and were arrested in the G2 phase of the cell cycle,
while non-tumorigenic cells were prone to radiation-
induced apoptosis. Finally, in lineage-tracking experi-
ments we observed that fractionated radiation not only
spared CICs but also mobilized CICs from a quiescent/
G0 phase of the cell cycle into actively cycling cells,
while the surviving non-tumorigenic cells were driven
into senescence.
Materials and methods
Cell culture
Human MCF-7 and T47D breast cancer cell lines were
purchased from American Type Culture Collection
(Manassas, VA, USA). MCF-7-ZsGreen-cODC and
T47D-ZsGreen-cODC were obtained as described in
Vlashi et al. [13]. All cells were cultured in log-growth
phase in Dulbecco’s Modified Eagle Medium (DMEM)
(Invitrogen, Carlsbad, CA, USA) (supplemented with
10% fetal bovine serum (Sigma Aldrich, St Louis, MO,
USA) and penicillin and streptomycin cocktail (Sigma
Aldrich)) and were grown in a humidified incubator at
37°C with 5% CO2.
Radiation
Cells were irradiated at room temperature with a
137Cs
laboratory irradiator (Mark I, JL Shephard, San Fer-
nando, CA, USA) at a dose rate of 4.95 Gy/minute for
t h et i m er e q u i r e dt oa p p l yap r e s c r i b e dd o s e .F o rf r a c -
tionated radiation of 2 or 3 Gy, cells were irradiated on
eight or five consecutive days, respectively. The single
dose was applied at the same time as the last dose of
fractionated radiation. Corresponding controls were
sham irradiated. Cell proliferation, number of stem cells,
and sphere forming assays were performed 48 h after
the last fraction of radiation.
Flow cytometry
After fractionated radiation, CD24 and CD44 expression
was analyzed in cells derived from monolayer cultures
following incubation with trypsin-EDTA and passage
through a 40 μms i e v e .A tl e a s t1 0
5 cells were pelleted
by centrifugation at 500 × g for five minutes at 4°C,
resuspended in 10 μL of monoclonal mouse anti-human
CD24-fluorescein isothiocyanate (FITC) antibody (BD
Pharmingen, San Jose, CA, USA) and a monoclonal
mouse anti-human CD44-phytoerythrin (PE) antibody
(BD Pharmingen), and incubated for 20 minutes at 4°C.
Corresponding isotype control APC-conjugated antibo-
dies (BD Pharmingen) and isotype control PE-conju-
gated antibodies (BD Pharmingen) were used as controls
(Additional file 1). Three independent experiments were
performed.
We had previously shown [13] that breast cancer stem
cells could be identified via their low proteasome activ-
ity, which can be assessed by analyzing ZsGreen-cODC
protein accumulation. For 48 h after the last fraction of
radiation, cells were trypsinized and ZsGreen-cODC
expression was assessed by flow cytometry. Cells were
defined as ZsGreen-cODC positive if the fluorescence in
the FL-1H channel exceeded the fluorescence level of
99.9% of the empty vector-transfected control cells
(Additional file 2).
Immunofluorescence
Six day-old MCF-7-ZsGreen-cODC mammospheres
were transferred on glass slides by centrifugation in a
cytocentrifuge (Cytospin, Shandon Elliot, London, UK)
and fixed with 4% formaldehyde. The cells were incu-
bated in blocking buffer (2% Bovine Serum Albumin
(BSA), in phosphate buffer saline (PBS)) and antibodies
(anti-CD44 APC-conjugated antibody (BD Pharmingen)
and anti-CD24 PE-conjugated antibody (BD Pharmin-
gen)) were added for one hour at room temperature.
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added for nuclear staining. The slides were visualized
with an Olympus IX71 inverted fluorescent microscope.
Grayscale images were merged using the ImageJ soft-
ware [18] and displayed in false colors.
Sphere forming capacity
After irradiation, cells were trypsinized and plated in
selection media (pheno-red free DMEM-F12, 0.4% BSA
(Sigma), 10 ml of B27 supplement (Invitrogen)/500 ml
of media, 5 μg/ml bovine insulin (Sigma), 4 μg/ml
heparin (Sigma), 20 ng/ml fibroblast growth factor 2
(bFGF, Sigma) and 20 ng/ml epidermal growth factor
(EGF, Sigma)) into 96-well plates, ranging from 1 to 256
cells/well. Growth factors, EGF, bFGF and heparin, were
added every three days, and the cells were allowed to
form spheres for 20 days. The number of spheres
formed per well was then counted and expressed as a
percentage of the initial number of cells plated. Cells
were also plated in selection media into 100 mm sus-
pension dishes at 10,000 cells/ml, and allowed to form
spheres for 15 days, these cells were used for secondary
sphere forming experiments. The same protocol was
used after the secondary sphere forming assays, in order
to plate cells for analyzing the formation of tertiary and
quaternary spheres. Three independent experiments
were performed.
Determining the number of cell divisions
We used the red fluorescent lipophilic dye PKH26 for
proliferation tracking. Cells were trypsinized to obtain a
single cell suspension and stained with the membrane-
labeling dye PKH26 according to manufacturer’sp r o t o -
col (Sigma Aldrich). Briefly, cells were washed twice
with PBS to remove exogenous proteins. Immediately
before staining, cells were dispersed in 1 ml of Diluent
C (an iso-osmotic, salt-free staining vehicle) at a con-
centration twice the desired final staining concentration
(20 × 10
6 cells/mL). In parallel, a 2× solution of the
PKH26 dye was prepared by diluting 4 μl of the ethano-
lic dye stock solution (4 μM) into 1 ml of Diluent C in
a separate tube. Rapidly dispensing and admixing an
equal volume of 2× cell solution into the 2× dye solu-
tion initiated the staining. After two to three minutes at
room temperature, the staining was stopped by adding
an equal volume of fetal bovine serum (FBS). Stained
cells were then washed twice in medium, counted, and
plated at 200,000 cells per 100 mm culture dish. Homo-
geneous staining between CICs and non-tumorigenic
cells was immediately verified by flow cytometry (FL-2
Channel) (Additional file 3), and the mean FL-2 fluores-
cence at this time was considered as time 0 (Mean FL-2
(t0)). Forty-eight hours after the last fraction of radia-
tion, cells were trypsinized, and the remaining PKH26
staining was analyzed by flow cytometry [Mean FL-2
(tsample)]. The number of cell divisions was calculated
using the following formula:
Number of cell divisions =log [M ean FL-2(t )/Mean FL -2(t 20 s sample )]
Cell cycle and G0 phase analysis
After fractionated radiation, cells were stained according
to Darzynkiewicz et al. [19]. Briefly, cells were trypsi-
nized and rinsed with HBSS/1 mM HEPES/10% FBS.
DNA was stained with 1 μg/ml Hoechst 33342 in
HBSS/1 mM HEPES/10% FBS solution/50 μM Verapa-
mil, 45 minutes at 37°C, followed by RNA staining with
3.3 μM pyronin Y (PY) for 45 minutes at 37°C. Finally,
cells were rinsed with HBSS/1 mM HEPES/10% FBS
solution, and resuspended in PBS. At least 100,000 cells
were analyzed by flow cytometry. ZsGreen-cODC
expression was analyzed in FL-1H, PY in FL-2H and
Hoechst 33342 in FL-5A.
b-galactosidase staining for cellular senescence
b-galactosidase-positive cells were detected by the
method of Dimri et al. [20]. Briefly, cells were washed
two times with PBS and then fixed with PBS/2% formal-
dehyde/0.2% glutaraldehydes o l u t i o nf o rf i v em i n u t e s .
Cells were then washed again two times with PBS. After
the last wash, staining solution was added (1 mg/ml 5-
bromo-4-chloro-3-inolyl-b-D-galactoside (X-gal) (20
mg/ml stock, in dimethyformamide), 40 mM citric acid/
sodium phosphate, pH 6.0, 5 mM potassium ferrocya-
nide, 5 mM potassium ferricyanide, 150 mM NaCl, 2
mM MgCl2) and cells were incubated in a 37°C for 18
h. After incubation, cells were washed two times with
PBS and visualized with an Olympus IX71 inverted
fluorescent microscope. The percentage of b-galactosi-
dase-positive cells was counted in 10 random fields at
20× magnification.
Statistical methods
All data are represented as means +/- standard error
means (SEMs). A P-value of ≤ 0.05 in a paired two-
sided Student’s t-test was considered to indicate statisti-
cally significant differences.
Results
CICs population in breast cancer retain self-renewal
capacity and multi-lineage potency after fractionated
radiation
We have previously reported that fractionated radiation
(5 × 3 Gy) increased the number of breast CICs in
established cell lines by approximately two-fold. How-
ever, this increase was restricted to cells floating on top
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adherent cell population [9]. In the present study, we
looked into possible increases in CSC numbers in the
adherent population, focusing on the kinetics of changes
in the size of the CICs population. Monolayer cultures
of MFC-7 and T47D breast cancer cells were grown
under standard conditions and irradiated with 0, 2, 2 ×
2 ,4×2 ,6×2 ,o r8×2G yi nd a i l yf r a c t i o n s .A f t e rt h e
last fraction, the cells were incubated for another 48
hours to simulate a typical weekend treatment gap
applied in clinical radiation oncology. The size of the
CD24
-/low/CD44
high population was analyzed by flow
cytometry (Figure 1A, Table 1). For MCF-7 cells (Figure
1A, B, Table 1) the largest increase in the percentage of
CD24
-/low/CD44
high cells was seen 48 hours after the 6
× 2 Gy treatment was applied (three-fold increase, P =
0.029). However, the CD24
-/low/CD44
high cell numbers
subsequently returned to control levels after another
two fractions of 2 Gy were applied, indicating that at a
dose of 8 × 2 Gy eliminates CICs population and non-
tumorigenic cells at the same rate. Interestingly, we also
observed an increase in the percentage of CD24
-/low/
CD44
high cells for the T47D cell lines (Figure 1C, Table
1) however, with slightly different kinetics. In T47D, the
maximum increase of CD24
-/low/CD44
high cell popula-
tion was observed 48 hours after a fractionated dose of
4 × 2 Gy was applied (6.9-fold increase, P = 0.001).
Similarly to MCF-7, eight daily fractions of 2 Gy seemed
to eliminate CICs and non-tumorigenic cells at the
same rate.
The generation of mammospheres from single cells
seeded at clonal densities has been proven a valuable
tool for assessing the self-renewal capacity of CICs
[ 1 4 ] .T h e r e f o r e ,w ee m p l o y e dt h i ss t r a t e g yt oa n a l y z e
the effect of radiation on the self-renewal capacity of
breast cancer stem cells in two different cell lines,
MCF-7 and T47D. Both cell lines were irradiated with
a single dose, or daily fractions of 2 Gy, and 48 hours
after the last dose the irradiated cells and controls
were plated into serum-free conditions at clonal densi-
ties. After the cells were allowed to form spheres for
20 days, sphere-forming capacity was analyzed by
counting the spheres formed. The primary sphere
forming capacity of the MCF-7 cell line followed a
biphasic pattern, with a significant increase in sphere-
forming capacity when the cells were treated with a
single dose of 2 Gy (P = 0.01), and a fractionated dose
of 6 × 2 Gy (P =0 . 0 3 5 )o r8×2G y( P =0 . 0 0 2 ) ,w h i l e
the intermediate doses of 2 × 2 Gy (P =0 . 1 4 )a n d4×
2G y( P = 0.20) did not have an effect on sphere-form-
ing capacity (Figure 2A). Secondary sphere formation
seemed to also follow the same biphasic pattern,
although none of the treatments led to a significant
change in sphere-forming capacity. Secondary sphere-
formation was only slightly increased in cells derived
from primary spheres treated with 2 × 2 Gy (P = 0.06).
Figure 1 Radiation response of cells in adherent monolayer cultures. Fluorescence-activated cell-sorting (FACS) analysis to measure CD44
and CD24 expression of cells derived from MCF-7 monolayer cultures. (A) FACS dot plots are shown from one representative experiment in
MCF-7. Bar graphs show the means (+/- SEM) from three independent experiments with MCF-7 (B) and T47D (C).
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sphere formation in irradiated MCF-7 cells (Figure 2A),
we observed a dose-dependent increase in primary
sphere formation in T47D cells, with a two-fold (P =
0.018) maximum increase at the highest dose of 8 × 2
Gy (Figure 2B). T47D secondary sphere-formation was
also dose-dependent. In contrast to MCF-7 cells, which
achieved a maximal effect in secondary sphere formation
at 2 × 2 and 8 × 2 Gy (1.9- and 1.8-fold increase respec-
tively), sphere formation in T47D was maximal after 6 ×
2 Gy (2.2-fold increase, P = 0.037) (Figure 2B).
Interestingly, even though the primary sphere-forming
capacity was comparable for non-irradiated control cells
from both cell lines, we failed to propagate spheres from
MCF-7 cells beyond the second generation (Figure 2A,
C). However, we were able to generate tertiary and qua-
ternary spheres from the T47D cells. Tertiary sphere
formation in this cell line continued to show a signifi-
cant increase when cells were treated with 2 × 2 or 4 ×
2G y( P =0 . 0 0 1a n dP = 0.006 respectively). All other
radiation treatments had no effect on tertiary sphere
formation (Figure 2B). Finally, in the fourth generation
of spheres, radiation-induced increases in the number of
CICs were lost and the mean frequency of CICs was
2.16% regardless of the radiation dose applied (Figure
2B).
Low proteasome activity characterizes a sub-population
of CD24
-/low/CD44
high breast CICs
Recently, we demonstrated that glioma and breast cancer
initiating cells present a lack of 26S proteasome activity
[13]. Therefore, the MCF-7 and T47D cell lines were
engineered to express the fusion protein between the
green fluorescent protein ZsGreen and the C-terminus of
the murine orthinine decarboxylase (cODC). The latter is
recognized by the 26S proteasome in an ubiquitin-inde-
pendent manner, leading to instant degradation of the
fusion protein in cells with proteasome activity but accu-
mulates in CICs, which lack proteasome activity.
As expected, when breast cancer cells were enriched for
cancer stem cells by growing them as mammospheres
under serum-free conditions, the number of ZsGreen-
Table 1 Comparison of fractionated irradiation effect on CIC population, CICs markers and corresponding sphere
forming capacity.
MCF-7
CD24
Low/-/CD44
Hight ZsGreen-cODC
+
Dose % of CICs (+/- SEM) Sphere forming capacity Sphere forming capacity % of CICs (+/- SEM) Dose
0 3.01 (+/- 0.61),
P value
9.4 (+/- 0.5),
P value
12.32 (+/- 2.01),
P value
2.17 (+/- 0.47),
P value
0
2 6.54 (+/- 1.95),
P = 0.095
13.49 (+/- 1.32),
P = 0.01
15.25 (+/- 3.2),
P = 0.661
3.70 (+/- 0.52),
P = 0.051
3
2 × 2 8.04 (+/- 1.47),
P = 0.036
10.76 (+/- 0.96),
P = 0.137
17.54 (+/- 4.15),
P = 0.096
3.13 (+/- 0.53),
P = 0.252
2×3
4 × 2 8.56 (+/- 1.21),
P = 0.020
11.85 (+/- 1.81),
P = 0.198
17.93 (+/- 2.33),
P = 0.051
6.73 (+/- 1.33),
P = 0.141
3×3
6 × 2 9.10 (+/- 1.04),
P = 0.029
11.85 (+/- 1.48),
P = 0.035
24.52 (+/- 4.50),
P = 0.048
11.26 (+/- 2.06),
P = 0.091
4×3
8 × 2 4.78 (+/- 0.34)
P = 0.229
11.85 (+/- 1.27),
P = 0.002
25.37 (+/- 5.2),
P = 0.039
12.64 (+/- 1.91),
P = 0.044
5×3
T47D
CD24
Low/-/CD44Hight ZsGreen-cODC+
Dose % of CICs (+/- SEM) Sphere forming capacity Sphere forming capcity % of CICs (+/- SEM) Dose
0 0.35 (+/- 0.06),
P value
9.46 (+/- 2.20),
P value
3.35 (+/- 2.01),
P value
2.47 (+/- 0.88),
P value
0
2 0.34 (+/- 0.03),
P = 0.868
6.74 (+/- 1.31),
P = 0.014
3.13 (+/- 2.69),
P = 0.231
4.31 (+/- 1.13),
P = 0.029
3
2 × 2 0.43 (+/- 0.08),
P = 0.471
13.76 (+/- 4.01),
P = 0.146
6.48 (+/- 3.14),
P = 0.091
9.72 (+/- 2.81),
P = 0.068
2×3
4 × 2 2.04 (+/- 0.12),
P = 0.001
12.74 (+/- 4.58),
P = 0.157
9.96 (+/- 2.33),
P = 0.049
16.09 (+/- 5.57),
P = 0.103
3×3
6 × 2 0.68 (+/- 0.04),
P = 0.007
17.99 (+/- 5.17),
P = 0.027
12 (+/- 2.66),
P = 0.033
24.06 (+/- 4.15),
P = 0.025
4×3
8 × 2 0.29 (+/- 0.01),
P = 0.449
18.92 (+/- 5.83),
P = 0.018
7.65 (+/- 2.55),
P = 0.055
21.133 (+/- 1.87),
P = 0.015
5×3
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+ cells increased (Figure 3A). In order to compare
the CD24
-/low/CD44
high population with the ZsGreen-
cODC
+ population, we stained the engineered cells for
CD24 and CD44 surface markers. ZsGreen-cODC
+ cells
did not express CD24 (Figure 3B, top panel), but
expressed a high level of CD44 (Figure 3B, bottom panel).
However, not all CD24
-/low/CD44
high cells were positive
for ZsGreen-cODC, indicating that ZsGreen-cODC
+ cells
constituted a sub-population of the CD24
-/low/CD44
high
population.
In the following studies, we used this intrinsic prop-
erty of breast CICs to accumulate fluorescent ZsGreen-
cODC protein to identify and track breast CICs.
Fractionated radiation increases the population of CICs
with low proteasome activity in breast cancer
In order to confirm the effect of fractionated radiation
on CICs observed using CD24
-/low/CD44
high CICs mar-
kers, we used the intrinsic low proteasome activity of
CICs to re-evaluate the effect of fractionated radiation
on CICs in a heterogeneous monolayer population.
MCF-7 and T47D monolayer cultures, stably expres-
sing ZsGreen-cODC protein were treated with daily
f r a c t i o n so f3G yf o rat o t a ld o s eo f0 ,3 ,6 ,9 ,1 2 ,o r1 5
Gy or a single dose of 8.5 Gy, corresponding to the biolo-
gical equivalent for 5 × 3 Gy, and the percentage of
ZsGreen-cODC
+ CICs was analyzed 48 hours after the
last dose.
Similar to the response to daily fractions of 2 Gy on
the percentage of MCF-7 CD24
-/low/CD44
high cells, the
lower doses of 3 and 2 × 3 Gy did not affect the number
of ZsGreen-cODC
+ CICs (P =0 . 0 5 2f o r3G y ,a n dP =
0.252 for 2 × 3 Gy), while higher doses of 3 × 3, 4 × 3,
and 5 × 3 Gy increased ZsGreen-cODC
+ CICs up to
five-fold in a dose-dependent manner (P = 0.044) (Fig-
ure 4A, B, Table 1). This was also found in T47D with a
ten-fold maximum increase at 4 × 3 Gy (P = 0.025) (Fig-
ure 4D, Table 1).
To compare the effect of 5 × 3 Gy with a biological
equivalent single dose, we also irradiated cells with a
single dose of 8.5 Gy at the same time the last fraction
of radiation was applied. Interestingly, while a fractio-
nated regimen of 5 × 3 Gy increased the CICs popula-
tion, the biologically equivalent single dose of 8.5 Gy
did not affect this population (MCF-7: P =0 . 5 ;T 4 7 D :P
= 0.12) (Figure 4B, D), indicating that tumorigenic
Figure 2 Long term self-renewal capacity after fractionated radiation. CICs number was evaluated by sphere forming capacity for MCF-7
(A) and T47D (B) for four sequential generations. (C) Maintenance of self-renewal capacity of untreated breast CICs over four generations. Means
(+/- SEM) of at least three independent experiments are shown.
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tivity to single high doses of radiation.
Next, in order to compare the effect of daily 2 Gy and
3 Gy fractions treatment on CICs population, we per-
formed sphere-forming capacity assays with cells irra-
diated with 3 Gy daily fractions or a single dose of 8.5
Gy. Forty-eight hours after the last dose of radiation,
cells were trypsinized and plated at clonal densities in
serum-free conditions. After three weeks, mammo-
spheres were counted to evaluate the effect of 3 Gy
daily fractions on sphere formation/number of CICs.
Again, 4 × 3 or 5 × 3 Gy induced a maximum increase
in MCF-7 sphere formation by 3.6-fold (P = 0.033) and
at w o - f o l di n c r e a s ei nT 4 7 D( P = 0.039) (Figure 4C, E,
Table 1). In contrary, a single dose of 8.5 Gy did not
affect sphere formation in MCF-7 (P =0 . 1 3 4 )o ri n
T47D (P = 0.098) (Figure 4C, E).
Fractionated radiation induced proliferation of a
subpopulation of CICs
The increase in the ZsGreen-cODC
+ population of CICs
could result from absolute or relative increases of cell
numbers in this population. In an effort to better under-
stand the nature of this increase, we decided to track
the proliferation of ZsGreen-cODC
+ CICs and non-
tumorigenic ZsGreen-cODC
- cells. For this purpose, we
labeled the cell membrane using PKH26, and evaluated
the mean fluorescence intensity at the time of staining
and 48 h after the last dose of radiation by flow cytome-
try. PKH26 stains the membranes of CICs or non-
tumorigenic cells with the same bright homogeneous
red fluorescence (Additional file 3). This homogeneous
red fluorescence is partitioned between daughter cells
during each cell division. Because daughter cell fluores-
cence intensities are approximately halved after each
division, the fluorescent intensity of a cell at a certain
time point relative to the fluorescent intensity at the
time of initial staining provides information about how
many divisions the cell has undergone (Figure 5A, D).
In untreated cells (0 Gy), PKH26 mean fluorescence
analysis of the total population indicated that MCF-7
and T47D underwent 4.3 (+/- 0.46) and 4.85 (+/- 0.58)
divisions respectively (Figure 5B, E, red bars at 0 Gy) in
a seven-days time period, which compares well to the
published doubling times of these cell lines [16]. Non-
tumorigenic ZsGreen-cODC
- cells on average divided
4.88 (+/- 0.58) and 5.03 (+/- 0.54) times in seven days,
in MCF-7 and T47D respectively (Figure 5B, E, blue
bars at 0 Gy), while the population of CICs ZsGreen-
cODC
+ showed a much lower number of divisions in
this time period with a mean of 2.16 (+/- 0.45) and 2.3
(+/- 0.5) divisions in MCF-7 and T47D respectively
Figure 3 ZsGreen-cODC
+ cells are a subpopulation of CD24
low/-/CD44
+ stem cell-containing population and lead to tumor growth.( A)
Confluent MCF-7-ZsGreen-cODC monolayer (top panel) and spheres (bottom panels). ZsGreen-cODC+ cells are enriched in mammospheres. (B)
Immunofluorescence of CD24 (red, top panel) and CD44 (red, bottom panel) reveals an overlap between ZsGreen-cODC-positive cells and the
subpopulation CD24
low/-/CD44
+ in MCF-7-ZsGreen-cODC mammospheres.
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of the experiment, which was consistent with the slow-
cycling nature of CICs [21].
Treatment with fractionated radiation resulted in a
dose-dependent increase in the mean fluorescence (Fig-
ure 5A, D) indicating declining numbers of cell divisions,
from 4.3 (+/- 0.46) and 4.85 (+/- 0.58) divisions at 0 Gy
to 2.22 (+/- 0.44, P = 0.012) and 3.14 (+/- 0.62, P =
0.009) divisions at 5 × 3 Gy in MCF-7 and T47D, respec-
tively (Figure 5B, E). While the decrease in the number of
divisions of non-tumorigenic ZsGreen-cODC
- cells
mostly reflected the decrease in proliferation of the total
population of cells (MCF-7: P = 0.028; T47D: P = 0.008)
(Figure 5B, E, red and blue bars), the proliferation of
CICs was not significantly affected by fractionated
irradiation, with 1.4 (+/- 0.34, P = 0.052) divisions occur-
ring in MCF-7 cells, and 2.2 (+/- 0.71, P = 0.67) divisions
in T47D (Figure 5B, E, green bars).
To further understand how the CICs population could
increase after radiation, while their proliferation rate
remained the same, we analyzed the radiation response
of non-dividing CICs (less than or equal to one division)
by evaluating the number of ZsGreen-cODC
+ cells which
did not lose the PKH26 staining after radiation by flow
cytometry (Figure 5C, F). While the non-dividing MCF-7
CICs population remained unchanged with a non-signifi-
cant increase from 11.64% to 15.23% (P = 0.11) (Figure
5C), the non-dividing T47D CICs population increased
from 9.99% to a maximum of 36.23% (P =0 . 0 0 3 )i na
dose-dependent manner (Figure 5F), thus indicating a
Figure 4 Radiation response of cells in monolayer cultures using ZsGreen-cODC as a CICs marker. Fluorescence-activated cell-sorting
(FACS) analysis was performed to measure ZsGreen-cODC expression of cells derived from MCF-7 or T47D monolayer cultures after radiation
treatment. (A) Representative dot blots of control and 5 × 3 Gy treatment of MCF-7 (a) or 4 × 3 Gy treatment of T47D (b). (B) The percent of
ZsGreen-cODC-positive (ZsGreen-cODC
+) cells was estimated by FACS in MCF-7 (a) and T47D (b) or plated for a sphere forming capacity assay
(C) for MCF-7 (a) and T47D (b) cells. White bars: untreated; Black bars: fractionated radiation; Grey bars: biological equivalent dose. Means (+/-
SEM) of at least three independent experiments are shown.
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Page 8 of 13differential radiation responses of CICs of different
origin.
Fractionated radiation eliminates non-tumorigenic cells
and mobilizes CICs from G0 phase into the cell cycle
To analyze how radiation increased the number of T47D
CICs while a substantial proportion of CICs (36.23%)
were not dividing more than one time during the obser-
vation period, we analyzed the effect of fractionated
radiation on cell cycle distribution and the population of
cells in the G0 phase of the cell cycle. Cell cycle analysis
revealed induction of a G2 arrest in the total population
of T47D cells after 5 × 3 Gy, from 14.7% to 21.5% (Figure
6A, left panels, 6B, red bars). This arrest was not found
in the non-tumorigenic cell population, which instead
underwent apoptosis (subG1 population increased 24-
fold, from 1.37% at 0 Gy to 33.1% at 5 × 3 Gy (Figure 6A,
middle panels, 6C blue bars)). Induction of apoptosis in
CICs was only minimally increased from 0.59% to 1.67%
(Figure 6A, right panels, 6C, green bars). CICs were
mostly arrested in the G2 phase of the cell cycle, with an
increase of cells in G2 phase from 11.9% to 27.5% (Figure
6A, right panels, 6B, green bars).
Cells in the G0 phase can be distinguished from cells
in the G1 phase of the cell cycle based on their RNA
content. Cells in G0 phase have the same quantity of
DNA as cells in G1 phase but lower amounts of RNA,
indicating lower transcriptional cell activity. In order to
assess the number of cells in G0, cells were stained with
a specific dye for DNA, Hoechst 33342, and a specific
d y ef o rR N A( p y r o n i nY ) ,4 8ha f t e rt h el a s td o s eo f
radiation and analyzed by flow cytometry.
After fractionated radiation with 5 × 3 Gy, the total
population of T47D cells showed a 3.6-fold increase of
Figure 5 Effect of fractionated radiation on the proliferation of CICs. ZsGreen-cODC expression and cell membrane PKH26 staining was
analyzed in MCF-7 or T47D monolayer cultures before and after radiation treatment. Cells were stained with PKH26, plated, and treated with the
appropriate radiation dose. Representative histograms of PKH26 fluorescence in the total population, non-tumorigenic and CICs populations in
MCF-7 (A) and T47D (D). Calculated numbers of cell divisions in MCF-7 (B) and T47D (E). Red bars: Total population; Blue bars: Non-tumorigenic
cells; Green bars: CICs. Quantification of non-dividing CICs after fractionated radiation MCF-7 (C) and T47D (F). White bars: untreated; Black bars:
fractionated radiation; Grey bars: biological equivalent 8.5 Gy treatment. Data from means (+/- SEM) of at least three independent experiments
are shown.
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Page 9 of 13cells in the G0 phase of the cell cycle, from 3.31% to
11.9% (Figure 7A, left panels, 7B, red bars). While the
increase of non-tumorigenic cells in G0 phase mostly
reflected the increase of G0 phase cells of the total
p o p u l a t i o n ,f r o m0 . 5 9 %a t0G yt o2 2 . 4 %a t5×3G y
( F i g u r e7 A ,m i d d l ep a n e l s ,7 B ,b l u eb a r s ) ,C I C sp r e -
sented the opposite response. In the non-irradiated con-
trol sample, approximately 25% of CICs were in G0
p h a s e( F i g u r e7 A ,r i g h tp a n e l s ,7 B ,g r e e nb a r s ) ,w h i c h
was consistent with the slow-cycling/quiescent nature of
CICs population. After irradiation with 5 × 3 Gy the
number of CICs in the G0 phase decreased four-fold to
6.56% (Figure 7A, bottom right panel, 7B, green bars),
indicating radiation-induced mobilization of CICs from
a G0/quiescent phase into a proliferating state.
Fractionated radiation induces senescence of non-
tumorigenic cells but not of CICs
C e l l si nG 0p h a s ec a nb ei naq u i e s c e n to rs e n e s c e n t
state. While CICs left the G0 state after radiation to
enter the cell cycle, the proportion of surviving non-
tumorigenic cells in the G0 phase of the cell cycle
increased after radiation. In order to distinguish
between senescence of non-tumorigenic cells and
quiescence, we performed a specific senescence stain-
ing via a b-galactosidase activity assay [20]. Therefore,
cells were stained for b-galactosidase activity using the
X-Gal substrate 48 h after the last dose of fractionated
radiation.
At 0 Gy, 2% of the total population was X-gal-posi-
tive/senescent cells (Figure 8A, B, red bars). The X-gal-
positive (X-Gal
+) cells were exclusively non-tumorigenic,
ZsGreen-cODC
- cells, indicating that untreated
ZsGreen-cODC
+ CICs in G0 phase were indeed quies-
cent cells and not senescent. Fractionated radiation
induced a dose dependent increase of X-Gal
+/senescent
cells in the total population,w i t ham a x i m a le f f e c ta t5
× 3 Gy (25-fold increase, P =0 . 0 9 )( F i g u r e8 A ,B ,r e d
bars). While 58% of non-tumorigenic, ZsGreen-cODC
-,
cells were X-Gal
+ after 5 × 3 Gy (P = 0.106) (Figure 8B,
blue bars), senescence was induced in only a small num-
ber of ZsGreen-cODC
+ CICs (6.4%) only after the maxi-
mum radiation dose of 5 × 3 Gy was applied (Figure 8B,
green bars). These results suggested that fractionated
radiation induces senescence preferentially in non-
tumorigenic cells, while CICs are resistant to radiation-
induced senescence.
Discussion
In this study we used two different, and independent,
CICs markers (CD24
-/low/CD44
high and lack of protea-
some activity) to confirm our previous observation [9]
that breast cancer cells areh i g h l ye n r i c h e df o rC I C s
after fractionated radiation. We demonstrated an
increase in sphere forming capacity, an operational
measure of the number of CICs [14], in cells derived
from irradiated breast cancer cultures from two differ-
ent cell lines, MCF-7 and T47D (Figures 1 and 2;
Figure 6 The effect of fractionated irradiation on cell cycle of non-tumorigenic cells and CICs. Cell cycle distribution of the total
population, non-tumorigenic cells and CICs, 48 h after the last dose of radiation analyzed by FACS. (A) Histograms of representative cell cycle
analysis, (B) G2 phase after 0 and 5 × 3 Gy of fractionated radiation, (C) SubG1 fraction after 0 and 5 × 3 Gy of fractionated radiation.
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Page 10 of 13Figure 7 The effect of fractionated irradiation on G0 phase of non-tumorigenic cells and CICs. FACS analysis of G0 phase in the total
population, non-tumorigenic cells and CICs, 48 h after the last dose of irradiation. Cell DNA was stained with Hoechst 33342, and the RNA was
stained with pyronin Y (PY), and cell fluorescence was analyzed on a flow cytometer. (A) Dot blots of DNA and RNA content. (B) Cells in G0 after
0 and 5 × 3 Gy fractionated irradiation. Data show one representative experiment.
Figure 8 The effect of fractionated irradiation on senescence induction of non-tumorigenic cells and CICs. After radiation treatment cells
were fixed and stained for b-galactosidase activity. (A) Representative pictures of cells after fractionated radiation regimen and b-gal assay. White
arrow: quiescent non-tumorigenic cells; red arrow: non-quiescent CICs; red star: quiescent CICs. (B) Bar graphs show quantification of senescent
cells in T47D. Red bars: total population; blue bars: non-tumorigenic cells; green bars: CICs. Means (+/- SEM) of at least two independent
experiments are shown.
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[17], sphere forming capacity assays have been widely
used to assess self-renewal capacity of cancer stem
cells. In theory, a growing sphere derives from a single
stem cell. Nevertheless, initially spheres may also
derive in part from early progenitors and clumping,
thereby introducing errors in the determination of the
absolute number of CICs. In order to make our results
more accurate, we performed subsequent generations
of sphere forming assays. Importantly, in T47D cells
the radiation-induced increase in self-renewal capacity
was maintained for at least three generations. This
ability of breast CICs to retain self-renewal capacity
after fractionated radiation was in agreement with our
previous studies reporting that fractionated radiation
of U87MG xenographs in nude mice increased the Ki-
67 labeling index of glioma CICs and increased the
ratio of CICs/non-tumorigenic cells in tumors 72 h
after the last radiation dose [13]. Our data are also
consistent with a previous study demonstrating that
glioma CICs were responsible for the re-growth of
glioma xenographs after radiation treatment, and that
the surviving CD133
+ glioma CICs maintained self-
renewal capacity [22].
We previously reported that the relative radioresis-
tance of breast CICs resulted from their increased abil-
ity to scavenge radiation-induced free radicals, which
ultimately cause DNA damage after irradiation [9], an
observation reproduced by others independently [10].
While this relative radioresistance can explain relative
increases in CICs after radiation, it fails to provide an
explanation for absolute increases in CIC numbers. To
address this question we focused on the effects of frac-
tionated radiation on proliferation and cell cycle distri-
bution of breast CICs. Here we demonstrate that,
consistent with a radiation-induced cell cycle arrest,
the mean number of divisions performed by non-
tumorigenic breast cancer cells decreased after fractio-
nated radiation, while fractionated radiation did not
affect the overall proliferation rate of CICs. Instead,
the proliferation rate of the CICs population remained
constant regardless of the radiation dose applied (Fig-
ure 5B, E). There were two possible explanations for
this observation: 1) all the CICs divided at the same
rate, and this rate is not affected by fractionated radia-
tion, and 2) one sub-population of CICs stopped to
divide after fractionated radiation, while the other sub-
population divided faster, resulting in a constant over-
all proliferation rate of the entire CIC population. Our
results indicate that breast CICs of different origin
show differential responses to fractionated irradiation
with MCF-7 CICs being homogenously radioresistant
(Figure 5C), while CICs from the T47D cell line
respond heterogeneously (Figure 5F). Furthermore, cell
cycle analyses revealed that a substantial number of
non-tumorigenic cells were apoptotic after a 5 × 3 Gy
(Figure 6) and that a large proportion of the surviving
non-tumorigenic cells underwent senescence (Figure
8). In contrast, CICs did not show radiation-induced
apoptosis. A sub-population of CICs was arrested in
the G2 phase of the cell cycle after fractionated radia-
tion (Figure 6A, B), explaining the increase in the
number of non-dividing CICs (Figure 5F). Additionally,
the percentage of CICs in the G0 phase significantly
decreased after radiation treatment. This indicated that
induction of quiescence or senescence was not an
explanation for the radiation-induced increase of the
non-dividing sub-population of CICs. Furthermore, our
data suggest that after radiation treatment a sub-popu-
lation of CICs, which were initially quiescent (G0),
were recruited into the cell cycle. Sham and Durand
have previously demonstrated that fractionated irradia-
tion of spheroid cells (now recognized to be enriched
for CICs) presented an un-modified growth fraction
but a dramatic decrease of cell loss factor, 48 h after
the last dose [23]. Considering our observations this
decrease of cell loss factor, at the 48 h time point,
could be explained by the enrichment for and the dra-
matic increase in proliferation of the CIC population,
which could mask the loss of non-tumorigenic cells
caused by induction of apoptosis.
Conclusions
While we and others previously described the radiation
resistance phenotype of CICs, the extent of the remain-
ing self-renewal capacity of the CIC population after
f r a c t i o n so fr a d i a t i o nw a su n k n o w n .I nt h i ss t u d y ,w e
demonstrated that radiation resistant CICs in breast
cancer are not only viable after treatment with fractio-
nated radiation, but retain their self-renewal capacity
over several generations. Most importantly, the increase
of their self-renewal capacity indicated that irradiated
CICs may become more aggressive than populations of
non-irradiated CICs. Therefore, since the breast CIC
population contains a population of cells with the capa-
city to re-populate a tumor, which could be more
tumorigenic and metastatic after treatment, it would be
very important that this population of breast cancer
cells be targeted during fractionated radiation. Such a
strategy may offer a novel approach to improve patient
outcome in the future.
Additional file 1: Figure S1. Control gate of CD24 and CD44 analysis
(Figure 1). Fluorescence-activated cell-sorting (FACS) analysis was
performed to measure non-specific binding of anti-mouse isotype
control PE-conjugated and anti-mouse isotype control APC-conjugated
antibodies, and effects of radiation treatment on cell auto-fluorecence.
Click here for file
[http://www.biomedcentral.com/content/supplementary/bcr2479-S1.pdf]
Lagadec et al. Breast Cancer Research 2010, 12:R13
http://breast-cancer-research.com/content/12/1/R13
Page 12 of 13Additional file 2: Figure S2. Control gate of ZsGreen-cODC analysis
(Figure 4). Cells stably transfected with an empty control vector were
irradiated with 5 × 3 Gy (right panel) or sham irradiated (left panel), and
cells were analyzed for green auto-fluorescence. Cells were defined as
ZsGreen-cODC positive if the fluorescence in the FL-1H channel exceeded
the fluorescence level of 99.9% of the empty vector control cells.
Click here for file
[http://www.biomedcentral.com/content/supplementary/bcr2479-S2.pdf]
Additional file 3: Figure S3. Control gate of cell membrane PHK26
staining efficiency (Figure 5). After cell membrane staining with PKH26
fluorescence was analyzed in the total population (left panel), non-
tumorigenic cells (middle panel), and CICs (right panel). No difference
was found for PKH26 efficiency staining between non-tumorigenic cells
and CICs.
Click here for file
[http://www.biomedcentral.com/content/supplementary/bcr2479-S3.pdf]
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